Abaxis to Repurchase Up to $40M of its Common Stock

Abaxis ABAX today announced that its Board of Directors has approved the repurchase of up to an aggregate of $40,000,000 of its Common Stock. The repurchases will be made from time to time on the open market at prevailing market prices or in negotiated transactions off the market. Clint Severson, chairman and chief executive officer of Abaxis, commented "We believe that the repurchase program is a good investment of available funds and underscores our commitment to enhancing shareholder value."
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: EarningsNewsBuybacksPress ReleasesHealth CareHealth Care Equipment
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!